Laser Hair Removal Medication Screening: The Questions Before You Fire

Her form said no medications. Then, halfway through the second underarm, she mentions she's been on doxycycline since March for her skin. Technician's holding a live handpiece. Client's half undressed. Clock's running. Now what?

Short version: ask five separate questions instead of one, hold anything you don't recognise or that shows up on a photosensitiser list rather than dialling the energy down, and leave every timing decision — pause, restart, how long — to the prescriber who wrote the script.

Drug screening is the part of consultation that gets rushed. It feels like paperwork and it slows the room down. It isn't paperwork — it's the question that decides whether the session runs, and most clinics ask it in a way that reliably produces the wrong answer. The wider contraindication picture (lesions, tattoos, pacemakers, pregnancy, recent sun) lives in the full session walkthrough. This takes the medication column alone, down to the level your front desk needs on a Friday.

One boundary. You won't find a stop-date here, and you shouldn't want one. What follows is how to ask, how to record, when to hold, and how to hand the question upward — operational orientation for clinic staff, not medical advice, and no substitute for clinical training or your local rules.

Your Intake Form Is Asking the Wrong Question

"Are you currently taking any medication?" A client on a retinoid cream, a daily supplement and a two-week antibiotic course will tick no to that. Not because she's hiding anything. Because in her head, medication means tablets from a doctor for something serious, and none of those three qualify.

So stop asking one question. Ask five, out loud, and let her answer each separately:

• Anything prescribed, including things you take every day and stopped thinking about? Blood pressure, thyroid, heart rhythm, contraception, antidepressants.
• Any course of anything in the last few months, even if you've finished it? Antibiotics especially. People finish a course and mentally file it as over.
• Anything you put on your skin? Prescription creams, acne gels, acid toners, exfoliating pads, whitening products. Name a few — recognition beats recall.
• Any supplement, vitamin or herbal product? Clients almost never count these as medicine.
• Anything at all for your skin, from anybody, ever? The catch-all. It's where oral acne treatment usually surfaces.

Who asks, and how often

Front desk collects it at booking, technician confirms it in the room. Two passes, because people remember things once they're sitting down and the conversation is about their skin rather than their card details.

Re-ask every visit. Not a glance at the file — an actual question. A course runs months, prescriptions change inside that window, and nobody thinks to phone the clinic about a new tablet. "Anything changed with medications since last time?" takes four seconds. Session six is not the same client as session one.

Oral Isotretinoin: Flag It, Don't Adjudicate It

Oral isotretinoin is where clinics tie themselves in knots, mostly because the received wisdom and the published evidence have drifted apart.

The received wisdom came from the drug labelling, which for years advised waiting six months after stopping before dermabrasion, laser skin resurfacing or waxing — a figure the 2017 ASDS review traces back to that labelling. The industry generalised it to cosmetic procedures at large, and half of it still repeats the number.

The evidence moved. The ASDS guidelines task force reviewed this in 2017 and concluded there wasn't sufficient evidence to justify delaying non-ablative treatment — hair removal lasers and lights included — in patients currently or recently exposed to isotretinoin. The panel drew its line elsewhere: mechanical dermabrasion and fully ablative laser resurfacing were the procedures it still advised against, while noting that superficial and focal dermabrasion may be safe in trained hands. A 2021 study in Dermatologic Surgery by Guduk and Demirci followed 52 patients treated with alexandrite, diode and Nd:YAG systems during systemic isotretinoin therapy and reported no scarring or keloid formation.

Encouraging. It still isn't your technician's decision.

Three practical reasons. Your device documentation may carry a contraindication list written before that consensus, and departing from a manufacturer's stated contraindications is a conversation with your insurer, not a judgement call in the room. The literature also separates ablative, wound-healing procedures from non-ablative hair removal — treat that distinction as load-bearing, since our own resurfacing documentation flags recent oral retinoid use as an abnormal-healing concern where the hair removal material doesn't. And her prescriber knows her dose, her month, her history. You know none of it.

The referral note that actually comes back

Open-ended letters to a busy prescriber go unanswered for weeks. Ask a closed question instead. Four lines, sent the same day:

1. Who the client is and what she's booked for — non-ablative 808nm hair removal, named body areas, no skin removal, no wound created.
2. What she has told you she's taking, and since when.
3. The single question: is there any reason to delay this treatment, and if so, until when?
4. A reply-by date and a direct line, because the booking is holding a slot.

File the answer. Date it. Note who gave it. If the reply is "no objection", that sentence in the record is worth more than any policy you could write yourself.

Photosensitising Drugs, and the List Hiding Behind "e.g. Tetracycline"

Open almost any device manual in this category and the first contraindication reads roughly the same: clients taking drugs which cause photosensitivity, for example tetracycline. Our own diode platform manuals use exactly that phrasing. One example, then nothing. Staff read it, memorise tetracycline, and screen for one drug out of dozens.

The pharmacology literature is much broader. Blakely, Drucker and Rosen's 2019 review in Drug Safety names tetracycline and doxycycline, nalidixic acid, voriconazole, amiodarone, hydrochlorothiazide, naproxen, piroxicam, chlorpromazine and thioridazine among the most consistently implicated agents. Grouped the way a receptionist can hold in her head, that's roughly: some antibiotics, some diuretics and heart-rhythm drugs, some anti-inflammatories, some antifungals, some psychiatric medications.

Herbals count too. St John's wort is the one clients volunteer least and take most — the US National Center for Complementary and Integrative Health notes it can increase sensitivity to sunlight, particularly at higher doses. It comes off a supermarket shelf, so nobody files it under medicine.

The wavelength caveat your training probably skipped

Here's the honest part. Most documented drug photosensitivity reactions are driven by ultraviolet and visible light — that's the range the pharmacology keeps pointing at. A hair removal diode fires in the near infrared, well outside it. Sunburn physics and follicle-heating physics are not the same physics.

Does that make photosensitising drugs irrelevant on a diode? We're not going to tell you that, and neither should anyone selling you a machine. The contraindication is printed in your manual, your indemnity almost certainly references it, and her prescriber is the one qualified to weigh her drug against her treatment. Ask. Record the answer. Don't reason your way past a printed contraindication because the mechanism looks shaky to you.

The list isn't the whole column

Photosensitisers are one category, not the medication column. Our diode manuals also print anticoagulant use as a contraindication, and our European treatment protocol tells clients to avoid steroids around each session — neither has anything to do with light sensitivity. So the rule is broader: if a drug appears on your own device manual's contraindication list, it goes in the hold bucket whatever the mechanism. Read your manual's list. Don't work off this article's.

Topicals and Acids: Read the Skin, Not the Calendar

Topical retinoids, glycolic and salicylic products, benzoyl peroxide, exfoliating pads. These come up constantly, and clinics reach straight for a number of days.

Wrong instinct. Two clients on the same 0.05% retinoid cream can present with completely different skin — one calm and intact, one flaking along the jawline. A calendar rule treats them identically. Your eyes don't.

Have the technician assess what's in front of her. Visible peeling or flaking in the zone? Redness that wasn't there at consultation? Stinging when she washes? A barrier that looks compromised — tight, shiny, tender? Any yes and you're not treating that area today, whatever the calendar says.

Worth knowing topical retinoids aren't automatically the enemy here. Our clinical training material describes pre-treatment protocols where a low-strength topical retinoid, hydroquinone and a mild steroid are used deliberately on darker or sun-exposed skin to cut pigment risk before light-based treatment. Same molecule, opposite intent. So "she's on a retinoid" isn't a decision — it's a prompt to look closer, and if it's prescribed, to ask the prescriber about timing.

Three Buckets, One Decision

Technicians don't need a pharmacology course. They need a sorting rule that fits on a laminated card by the door.

• Proceed. Nothing declared, or something declared and already cleared in writing by the prescriber, with the note in the file. Also: an old finished course with nothing from the hold list below, no skin involvement and no reaction history. Treat normally.
• Hold and ask. Anything on the photosensitising groups above. Any current oral acne treatment. Any prescribed topical. Anything the client can name but can't explain. Anything the technician hasn't heard of. The session doesn't run today — the question goes out today.
• Hold and ask: anticoagulants and antiplatelets. Warfarin, the DOACs, clopidogrel, daily aspirin. Bruising and purpura risk, and anticoagulant use sits on our diode manuals' printed contraindication list — that alone parks it here, whatever the drug does to light.
• Hold and ask: systemic or potent topical corticosteroids. Oral prednisolone, a strong steroid cream on or near the treatment zone. Our own European session protocol tells clients to avoid steroids around treatment, so a client currently on them is a question for the prescriber, not a walk-in.
• Not today, regardless. Visibly irritated, peeling or broken skin in the zone. A client who says she reacted badly to sun or to a previous session while on this drug. A client who's unsure what she's taking and can't reach anyone who knows.

The rule that makes the card work is the boring one: unsure means hold. Never fire to avoid an awkward conversation. A rebooked appointment costs you a slot. A reaction costs you a slot, a refund, a complaint, and possibly a technician who never trusts her own judgement again.

Making the Policy Survive a Busy Friday

Policies fail on volume, not on principle. Four operational fixes.

Don't let a hold become a lost hour

Staff skip screening because a hold blows a hole in the day. Give them somewhere to put it. Convert the slot: full consultation, photography, baseline documentation, the aftercare briefing, a patch test elsewhere if the skin is clear and the query concerns a different zone. Client leaves looked after rather than turned away, and the room isn't dark. Book medication queries into the morning so answers land before the afternoon list.

Write it down in a form that survives staff turnover

Four fields per session, no more: what was declared, the date, where clearance came from (client statement, prescriber note, phone call with a name), technician's initials. That's your record if anything goes wrong. A shrug and "she said it was fine" isn't.

Have a script for the mid-session disclosure

It will happen — the doxycycline client from the top of this article is exactly this scenario — and the temptation is to finish the side you've started. Don't. Handpiece off the skin, cool the area, say plainly that you've been given new information and you'd rather check than guess. Most clients respect that instantly. Write down what she said, in her words. Rebook.

Train the question, not just the list

Role-play it. Ten minutes, new technician plays the client who says "no, nothing" and then mentions the antibiotic on the bed. Run it three times. That's a different skill from operating the DL-07 — cheaper to teach than parameter judgement, and the one that keeps you out of trouble.

Sort this out before the first paying client, not after the first incident. For the screening sheet, aftercare card and training sequence alongside the room setup, start with the hair removal solution overview, then tell us your treatment menu and we'll scope the configuration.

A client is on oral acne medication. Can we treat her or not?

Not a question your clinic answers alone. Flag it, send a closed question to her prescriber, treat the written reply as the decision. The published consensus on non-ablative hair removal around isotretinoin is more relaxed than the old six-month folklore — but the call belongs to whoever wrote the script, and your manual and insurer have a say in your policy.

What about supplements and herbal products — do those count?

They count, and they're the most under-reported category you'll deal with. St John's wort is the classic example; NCCIH notes increased sun sensitivity, particularly at higher doses. Clients don't consider a supermarket supplement to be medication, so name the category out loud rather than waiting for them to volunteer it.

Our technician doesn't recognise a drug name. What's the default?

Hold. Unrecognised means unscreened, and guessing from a half-remembered training slide is worse than a rebooking. Log the name exactly as spelled on the box, ask the prescriber, and put the client into a consultation or patch-test slot so the hour isn't wasted.

Can we just cut the energy down instead of postponing?

No. Lower fluence manages thermal load; it doesn't manage a question you haven't answered, and it quietly under-treats the client while pretending the problem is handled. Screening questions get answered, not dialled around.

1. Waldman A et al. ASDS Guidelines Task Force: Consensus Recommendations Regarding the Safety of Lasers, Dermabrasion, Chemical Peels, Energy Devices, and Skin Surgery During and After Isotretinoin Use. Dermatol Surg, 2017
2. Guduk SS, Demirci GT. Safety of Laser Hair Removal in Patients Receiving Systemic Isotretinoin for Acne Vulgaris. Dermatol Surg, 2021
3. Blakely KM, Drucker AM, Rosen CF. Drug-Induced Photosensitivity - An Update: Culprit Drugs, Prevention and Management. Drug Safety, 2019
4. St. John's Wort: Usefulness and Safety. US National Center for Complementary and Integrative Health (NCCIH)